PNR
47
5
PFG
36
3
INTU
60
6
GME
86
6
MET
56
2
RCL
62
3
SLG
41
3
CMCSA
45
3
R
63
2
CMI
45
2
CSCO
60
3
QCOM
46
6
PYPL
22
8
PNW
60
4
DGX
42
2
HRB
60
4
PPL
75
5
ECL
37
3
MPC
26
3
CAH
54
6
PNR
47
5
PFG
36
3
INTU
60
6
GME
86
6
MET
56
2
RCL
62
3
SLG
41
3
CMCSA
45
3
R
63
2
CMI
45
2
CSCO
60
3
QCOM
46
6
PYPL
22
8
PNW
60
4
DGX
42
2
HRB
60
4
PPL
75
5
ECL
37
3
MPC
26
3
CAH
54
6
Financhill
Back

Ligand Pharmaceuticals 10K Form

Sell
45

LGND
Ligand Pharmaceuticals

Last Price:
$103.98
Seasonality Move:
7.17%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2024-05-08 10Q LGND/Ligand Pharmaceuticals Quarterly
2023-11-09 10Q LGND/Ligand Pharmaceuticals Quarterly
2023-08-09 10Q LGND/Ligand Pharmaceuticals Quarterly
2023-05-08 10Q LGND/Ligand Pharmaceuticals Quarterly
2022-11-08 10Q LGND/Ligand Pharmaceuticals Quarterly
2022-08-09 10Q LGND/Ligand Pharmaceuticals Quarterly

Receive LGND News And Ratings

See the #1 stock for the next 7 days that we like better than LGND

LGND Financial Statistics

Sales & Book Value

Annual Sales: $167.1M
Cash Flow: $27.8M
Price / Cash Flow: 24.77
Annual Sales: $43.46
Price / Book: 2.42

Profitability

EPS (TTM): -0.16000
Net Income (TTM): $-4M
Gross Margin: $156.1M
Return on Equity: -0.51%
Return on Assets: -0.45%

Ligand Pharmaceuticals Earnings Forecast

Key Ligand Pharmaceuticals Financial Ratios

  • The Gross Profit Margin over the past 31 years for LGND is 93.37%.
  • The Selling, General & Administrative Expenses for LGND have been equal to 47.06% of Gross Profit Margin.
  • The Research & Development expenses have been 12.82% of Revenue.
  • The Net Earning history of LGND is -2.41% of Total Revenues.
  • Per Share Earnings over the last 31 years have been positive in 19 years.

Ligand Pharmaceuticals Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: LGND
CUSIP: 53220K
Website: ligand.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 8.93
Quick Ratio: 8.05

Price-to-Earnings

Trailing P/E Ratio: 39.38
Forward P/E Ratio: 15.01

LGND Technical Analysis vs Fundamental Analysis

Sell
45
Ligand Pharmaceuticals (LGND) is a Sell

Is Ligand Pharmaceuticals a Buy or a Sell?